(NYSE:AGL), NEW YORK, Jan. 03, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the “Class Period”). A class […]

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AGL GlobeNewswire January 03, 2026 NEW YORK, Jan. 03, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed

(NasdaqGM:ABVE), Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Above Food (ABVE) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Above Food and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato

ABOVE FOOD ALERT: Bragar Eagel & Squire, P.C. is Investigating Above Food Ingredients, Inc. on Behalf of Above Food Stockholders and Encourages Investors to Contact the Firm GlobeNewswire January 03, 2026 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Above Food (ABVE) To Contact Him Directly To Discuss

NEW YORK, NY / ACCESS Newswire / January 3, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Inovio Pharmaceuticals, Inc. ("Inovio" or the "Company") (NASDAQ:INO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Inovio and certain of its officers and/or directors

NEW YORK, NY / ACCESS Newswire / January 3, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Rezolute, Inc. ("Rezolute" or the "Company") (NASDAQ:RZLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Rezolute and certain of its officers and/or directors have

NEW YORK, NY / ACCESS Newswire / January 3, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Nektar Therapeutics ("Nektar" or the "Company") (NASDAQ:NKTR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Nektar and certain of its officers and/or directors have

NEW YORK, NY / ACCESS Newswire / January 3, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Anavex and certain of its officers and/or

NEW YORK, NY / ACCESS Newswire / January 3, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ:OM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Outset Medical and certain of its officers

NEW YORK CITY, NY / ACCESS Newswire / January 3, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Waldencast plc ("Waldencast" or the "Company") (NASDAQ:WALD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Waldencast and certain of its officers and/or directors